Cuthbert AW.- New horizons in the treatment of cystic fibrosis. British J Pharmacoly, 2010, 163, 173-183.
Smyth AR, Bell SC, Bojcin S, et al.- European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros, 2014, 13, 23-42.
Pettit RS, Fellner C.- CFTR Modulators for the Treatment of Cystic Fibrosis. PT, 2014, 39, 500-511.
De Boeck K, Zolin A.- The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros, 2014, 13, 403-409.
Gill DR, Hyde SC.- Basic science for the chest physician : delivery of genes into the CF airway. Thorax, 2014, 69, 962-963.
Döring D, Flume P, Heijerman H, et al., Consensus Study Group.- Treatment of lung infection in patients with cystic fibrosis : current and future strategies. J Cyst Fibros, 2012, 11, 461-479.
Gibson RL, Burns JL, Ramsey BW.- Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am J Respir Crit Care Med, 2003, 168, 918-951.
Woestenenk JW, Castelijns SJAM, Van Der Ent CK, et al.- Nutritional intervention in patients with Cystic Fibrosis : a systematic review. J Cyst Fibros, 2013, 12, 102-115.
Kashirskaya NY, Kapranov NI, Sander-Struckmeier S, et al.- Safety and efficacy of Creon® Micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. J Cystic Fibrosis, 2014, http://dx.doi. org/10.1016/j.jcf.2014.07.006
